Skip to main content
RT @DrKanikaMonga: Poor prognostic factors for MDA-5 ILD:
- Ferritin > 1000 ng/mL prior Rx
- GCO or consolidations in all lung fields
- Wor…

Kanika Monga, MD DrKanikaMonga

6 years 11 months ago
Poor prognostic factors for MDA-5 ILD: - Ferritin > 1000 ng/mL prior Rx - GCO or consolidations in all lung fields - Worsening of lung consolidations during Rx #ACR19 @RheumNow
RT @DrKanikaMonga: Myositis -- Ask for muscle biopsy when:
- high clinical suspicion w/ negative myositis specific antibodies
- high clinic…

Kanika Monga, MD DrKanikaMonga

6 years 11 months ago
Myositis -- Ask for muscle biopsy when: - high clinical suspicion w/ negative myositis specific antibodies - high clinical suspicion of inherited muscle disease - isolated elevated CPK - recalcitrant to treatment - atypical presentation #ACR19 @RheumNow
RT @Janetbirdope: Sjogrens RCT of Tocilizumab showed no benefit. Wonder re outcomes and pt selection. Maybe pick early pts with high inflam…

Janet Pope Janetbirdope

6 years 11 months ago
Sjogrens RCT of Tocilizumab showed no benefit. Wonder re outcomes and pt selection. Maybe pick early pts with high inflammatory markers or other organ involvement #ACR @RheumNow #Sjogrens abstr1904
RT @Janetbirdope: Tofacitinib works in Polyarticular JIA. Maybe new hope for kids with JIA and benefits of oral medication #ACR #ACR19 #JIA…

Janet Pope Janetbirdope

6 years 11 months ago
Tofacitinib works in Polyarticular JIA. Maybe new hope for kids with JIA and benefits of oral medication #ACR #ACR19 #JIA @RheumNow L23.
RT @DrKanikaMonga: Myositis-specific autoantibodies (MSA): an important tool to support the diagnosis of myositis

#ACR19 @RheumNow https:/…

Kanika Monga, MD DrKanikaMonga

6 years 11 months ago
Myositis-specific autoantibodies (MSA): an important tool to support the diagnosis of myositis #ACR19 @RheumNow https://t.co/vgW2wxkemr
RT @Janetbirdope: Certrolizumab pegol decreases uveitis in open label study of SpA with past uveitis and HLAB27 group enriched for recurren…

Janet Pope Janetbirdope

6 years 11 months ago
Certrolizumab pegol decreases uveitis in open label study of SpA with past uveitis and HLAB27 group enriched for recurrence. Pre and post Rx rates of uveitis were compared. 80% reduction of uveitis but uncontrolled and unblinded. #ACR #ACR19 @RheumNow
RT @Janetbirdope: 1/3 of pts using apremilast with PsA/SpA from Corrona data base are using it in combination with bDMARDs. Not sure how th…

Janet Pope Janetbirdope

6 years 11 months ago
1/3 of pts using apremilast with PsA/SpA from Corrona data base are using it in combination with bDMARDs. Not sure how they get reimbursement #ACR #ACR19 #psoriaticarthritis @RheumNow abstract 1481
RT @DrKanikaMonga: 2020 Gout Clinical Practice Guideline
❕Regardless of disease activity, conditionally recommend
- limit alcohol intake
-…

Kanika Monga, MD DrKanikaMonga

6 years 11 months ago
2020 Gout Clinical Practice Guideline ❕Regardless of disease activity, conditionally recommend - limit alcohol intake - limit purine intake - limit high-fructose corn syrup - if overweight/obese, recommend weight loss - against adding vitamin C supplementation #ACR19 @RheumNow
RT @DrKanikaMonga: @RheumNow 2020 Gout Clinical Practice Guideline
‼️ For allopurinol and febuxostat, strongly recommend starting at low do…

Kanika Monga, MD DrKanikaMonga

6 years 11 months ago
@RheumNow 2020 Gout Clinical Practice Guideline ‼️ For allopurinol and febuxostat, strongly recommend starting at low dose with subsequent dose titration to target over starting at higher dose ( ≤ 100 mg/d for allopurinol, ≤ 40 mg/d for febuxostat) #ACR19 @RheumNow
RT @EBRheum: All the NEW Clinical Practice Guidelines for GOUT!

1. Allopurinol is 1st line
2. Start ULT during flare!
3. No tx for asympt…

Mike Putman EBRheum

6 years 11 months ago
All the NEW Clinical Practice Guidelines for GOUT! 1. Allopurinol is 1st line 2. Start ULT during flare! 3. No tx for asymptomatic hyperuricemia Seems pretty reasonable - surprised no rec for MTX w/pegloticase #ACR19 @RheumNow Thank you to @philipcrobinson for posting slides! https://t.co/riwHGYNZ8T
RT @DrKanikaMonga: 2020 Gout Clinical Practice Guideline
42 recommendations (16 strong)
- 27 ULT management (13 strong)
- 5 Gout Flares (3…

Kanika Monga, MD DrKanikaMonga

6 years 11 months ago
2020 Gout Clinical Practice Guideline 42 recommendations (16 strong) - 27 ULT management (13 strong) - 5 Gout Flares (3 strong) - 5 Lifestyle recommendations - 4 Management of other medications - 1 Asymptomatic Hyperuricemia #ACR19 @RheumNow
RT @hausmannMD: Pericarditis is an inflammatory condition that causes chest pain, pericardial friction rub, pericardial effusion.

#ACR19 @…

Jonathan Hausmann MD hausmannMD

6 years 11 months ago
Pericarditis is an inflammatory condition that causes chest pain, pericardial friction rub, pericardial effusion. #ACR19 @RheumNow
RT @uptoTate: MAXIMISE results in axial manifestations of PsA. SEC met primary phase 3b ASAS 20 endpoint after inadequate NSAID response. h…

Dr. Rachel Tate uptoTate

6 years 11 months ago
MAXIMISE results in axial manifestations of PsA. SEC met primary phase 3b ASAS 20 endpoint after inadequate NSAID response. https://t.co/e1j03KOo1K #ACR19 @RheumNow abs#2880 https://t.co/UtSDJGAW2G
RT @philipcrobinson: The draft 2020 ACR #gout guidelines were presented at the last slot of the meeting. Big changes for ULT initiation #AC…

Philip Robinson philipcrobinson

6 years 11 months ago
The draft 2020 ACR #gout guidelines were presented at the last slot of the meeting. Big changes for ULT initiation #ACR19 @RheumNow [Slides attached] https://t.co/bHBzQ3xwX8
×